These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21826773)

  • 1. Actuation of asymmetric cyclopropanation catalysts: reversible single-crystal to single-crystal reduction of metal-organic frameworks.
    Falkowski JM; Wang C; Liu S; Lin W
    Angew Chem Int Ed Engl; 2011 Sep; 50(37):8674-8. PubMed ID: 21826773
    [No Abstract]   [Full Text] [Related]  

  • 2. Ruthenium-catalyzed hydroarylations of methylenecyclopropanes: mild C-H bond functionalizations with conservation of cyclopropane rings.
    Kozhushkov SI; Yufit DS; Ackermann L
    Org Lett; 2008 Aug; 10(16):3409-12. PubMed ID: 18630917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric cyclopropanation of olefins catalysed by Cu(I) complexes of chiral pyridine-containing macrocyclic ligands (Pc-L*).
    Castano B; Guidone S; Gallo E; Ragaini F; Casati N; Macchi P; Sisti M; Caselli A
    Dalton Trans; 2013 Feb; 42(7):2451-62. PubMed ID: 23202443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of an aryliridium-salen complex for highly cis- and enantioselective cyclopropanations.
    Kanchiku S; Suematsu H; Matsumoto K; Uchida T; Katsuki T
    Angew Chem Int Ed Engl; 2007; 46(21):3889-91. PubMed ID: 17431871
    [No Abstract]   [Full Text] [Related]  

  • 5. Axial ligand effects: utilization of chiral sulfoxide additives for the induction of asymmetry in (salen)ruthenium(II) olefin cyclopropanation catalysts.
    Miller JA; Gross BA; Zhuravel MA; Jin W; Nguyen ST
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3885-9. PubMed ID: 15900537
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapidly initiating ruthenium olefin-metathesis catalysts.
    Romero PE; Piers WE; McDonald R
    Angew Chem Int Ed Engl; 2004 Nov; 43(45):6161-5. PubMed ID: 15549743
    [No Abstract]   [Full Text] [Related]  

  • 7. trans-Cyclopropyl beta-amino acid derivatives via asymmetric cyclopropanation using a (Salen)Ru(II) catalyst.
    Miller JA; Hennessy EJ; Marshall WJ; Scialdone MA; Nguyen ST
    J Org Chem; 2003 Oct; 68(20):7884-6. PubMed ID: 14510571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azaarene cis-dihydrodiol-derived 2,2'-bipyridine ligands for asymmetric allylic oxidation and cyclopropanation.
    Boyd DR; Sharma ND; Sbircea L; Murphy D; Belhocine T; Malone JF; James SL; Allen CC; Hamilton JT
    Chem Commun (Camb); 2008 Nov; (43):5535-7. PubMed ID: 18997943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deactivation of ruthenium olefin metathesis catalysts through intramolecular carbene-arene bond formation.
    Vehlow K; Gessler S; Blechert S
    Angew Chem Int Ed Engl; 2007; 46(42):8082-5. PubMed ID: 17854014
    [No Abstract]   [Full Text] [Related]  

  • 10. Verdazyl radicals as redox-active, non-innocent, ligands: contrasting electronic structures as a function of electron-poor and electron-rich ruthenium bis(beta-diketonate) co-ligands.
    McKinnon SD; Patrick BO; Lever AB; Hicks RG
    Chem Commun (Camb); 2010 Feb; 46(5):773-5. PubMed ID: 20087516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural and functional roles of rhodium(II)-rhodium(II) dimers in multinuclear ruthenium(II) complexes.
    Cooke MW; Hanan GS; Loiseau F; Campagna S; Watanabe M; Tanaka Y
    Angew Chem Int Ed Engl; 2005 Aug; 44(31):4881-4. PubMed ID: 15995992
    [No Abstract]   [Full Text] [Related]  

  • 12. Covalent surface modification of a metal-organic framework: selective surface engineering via Cu(I)-catalyzed Huisgen cycloaddition.
    Gadzikwa T; Lu G; Stern CL; Wilson SR; Hupp JT; Nguyen ST
    Chem Commun (Camb); 2008 Nov; (43):5493-5. PubMed ID: 18997929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorinated dendritic TsDPEN-Ru(II) catalyst for asymmetric transfer hydrogenation of prochiral ketones in aqueous media.
    Wang W; Wang Q
    Chem Commun (Camb); 2010 Jul; 46(25):4616-8. PubMed ID: 20502775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium-catalyzed C-H/O-H and C-H/N-H bond functionalizations: oxidative annulations of cyclopropyl-substituted alkynes.
    Deponti M; Kozhushkov SI; Yufit DS; Ackermann L
    Org Biomol Chem; 2013 Jan; 11(1):142-8. PubMed ID: 23111695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2-symmetric dirhodium catalyst derived from a 1,2,2-triarylcyclopropanecarboxylate ligand: design, synthesis and application.
    Qin C; Boyarskikh V; Hansen JH; Hardcastle KI; Musaev DG; Davies HM
    J Am Chem Soc; 2011 Nov; 133(47):19198-204. PubMed ID: 22047062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular approaches to generate libraries of chelating bidentate ligands for homogeneous catalysis.
    Breit B
    Angew Chem Int Ed Engl; 2005 Oct; 44(42):6816-25. PubMed ID: 16217817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-switchable phase tags for recycling of homogeneous catalysts.
    Süssner M; Plenio H
    Angew Chem Int Ed Engl; 2005 Oct; 44(42):6885-8. PubMed ID: 16249989
    [No Abstract]   [Full Text] [Related]  

  • 18. Borane-mediated carbon dioxide reduction at ruthenium: formation of C1 and C2 compounds.
    Bontemps S; Vendier L; Sabo-Etienne S
    Angew Chem Int Ed Engl; 2012 Feb; 51(7):1671-4. PubMed ID: 22241554
    [No Abstract]   [Full Text] [Related]  

  • 19. Recoverable chiral salen complexes for asymmetric catalysis: recent progress.
    Zulauf A; Mellah M; Hong X; Schulz E
    Dalton Trans; 2010 Aug; 39(30):6911-35. PubMed ID: 20523932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-metal interactions in dinuclear ruthenium complexes containing bridging 4,5-di(2-pyridyl)imidazolates and related ligands.
    Slater JW; D'Alessandro DM; Keene FR; Steel PJ
    Dalton Trans; 2006 Apr; (16):1954-62. PubMed ID: 16609765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.